High-risk Features for Recurrence in Patients With Stage III Colorectal Cancer: A Retrospective Cohort Study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.For stage III colorectal cancer (CRC), preoperative bowel obstruction, N2 disease, and fewer than 17 examined lymph nodes are key indicators of recurrence risk. These factors help stratify patient prognosis and guide treatment decisions.
Area Of Science
- Oncology
- Gastroenterology
- Surgical Oncology
Background
- Risk stratification for recurrence in stage III colorectal cancer (CRC) remains less defined compared to stage II.
- Identifying robust prognostic factors is crucial for personalized treatment strategies in stage III CRC.
Purpose Of The Study
- To identify significant high-risk factors for recurrence in stage III colorectal cancer.
- To evaluate the clinical significance of these identified risk factors in predicting patient outcomes.
Main Methods
- Retrospective analysis of data from 120 stage III CRC patients who underwent curative colectomy (2014-2020).
- Logistic regression analysis was employed to pinpoint risk factors for recurrence.
- Clinical significance was explored through outcome stratification based on identified risk factors.
Main Results
- Three primary high-risk factors for recurrence were identified: preoperative bowel obstruction (OR=5.39), N2 disease (OR=3.12), and fewer than 17 examined lymph nodes (OR=3.17).
- Patient prognosis was significantly stratified by the number of these risk factors present.
- The effectiveness of adjuvant therapy was found to be dependent on the number of risk factors.
Conclusions
- Tumor obstruction, N-stage, and lymph node examination count are critical high-risk features predicting recurrence in stage III CRC.
- These findings offer valuable insights for clinicians in predicting and stratifying patient outcomes, potentially optimizing treatment selection.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...